Katherine Lewin News Reporter Merck is teasing data for efinopegdutide, a GLP-1/glucagon receptor co-agonist, in nonalcoholic steatohepatitis (NASH) and how it compares to Novo Nordisk’s semaglutide, with plans to share more detailed data from the study at the European Association for the Study of the Liver’s annual meeting later this month. Merck plans to use...
Tag: <span>Receptor</span>
Post
Treating gut pain via a Nobel prize-winning receptor
by Flinders University Credit: Pixabay/CC0 Public Domain Targeting a receptor responsible for our sense of touch and temperature, which researchers have now found to be present in our colon, could provide a new avenue for treating chronic pain associated with gastrointestinal disorders such as irritable bowel syndrome. A team examining the colon, led by Professor Hongzhen Hu...
Post
Receptor structure reveals new targets for cancer treatment
A molecule known as anaplastic lymphoma kinase (ALK) is a driver of several cancers, including pediatric neuroblastoma, B-cell lymphomas, and myofibroblast tumors. But for years much about this molecule — its role in the body, which molecules interact with it, what it looks like — has remained unknown, limiting efforts to target it for treatment....